NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Clinical Trials Week


Susan Hasty, Publisher
Table of Contents . . . April 27th, 2009
Non-Subscriber - Summaries Only
Related Areas: Other Issues in Clinical Trials Week | Other Publications

Non-Hodgkin Lymphoma - Pharmacyclics Initiates Phase 1 Clinical Trial of Novel Oral Btk Inhibitor for Refractory B-cell Non-Hodgkin's Lymphoma

Breast Cancer - Findings from Gunma University, Medical Department in breast cancer reported

Breast Cancer - Scientists at Gunma University release new data on breast cancer

Breast Cancer - Studies conducted at University Hospital on breast cancer recently published

Clinical Trial Research - Researchers at Food & Drug Administration target clinical trial research

Dialysis - New data from V. Belozeroff et al illuminate research in dialysis

Gastric Cancer - Investigators at Department of Agriculture target cardiology

Hepatitis C Virus - Data from I. Mederacke et al provide new insights into hepatitis C virus

Hepatitis C Virus - Findings from L. Coelmont and co-researchers advance knowledge in hepatitis C virus

Leukemia - Reports on leukemia findings from D. Hollyman and co-researchers provide new insights

Malaria - Research reports on malaria from S. Zakeri and colleagues provide new insights

Multiple Sclerosis - Research from Harvard University in the area of multiple sclerosis published

Non-Small Cell Lung Cancer - New non-small cell lung cancer research from A. Vergnenegre and colleagues discussed

Non-Small Cell Lung Cancer - Reports by A. Ravaioli and co-researchers describe recent advances in non-small cell lung cancer

Non-Small Cell Lung Cancer - Study findings from Tottori University broaden understanding of non-small cell lung cancer

Non-Small Cell Lung Cancer - Study results from N. Yoshimura et al provide new insights into non-small cell lung cancer

Pharmacokinetics - New pharmacokinetics research from J.P. Delord et al outlined

Pleural Effusion - New findings from Johann Wolfgang Goethe University describe advances in pleural effusion

Pancreatic Cancer Therapy - Study data from University of Toronto, Ontario Cancer Institute update understanding of pancreatic cancer therapy

Pharmacokinetics - Studies from K. Kutz et al in the area of pharmacokinetics described

Small Cell Lung Cancer Clinical Trial - Research from Addenbrooke's Hospital, Department of Oncology yields new data on small cell lung cancer clinical trial

Allergies - VentiRx Pharmaceuticals Initiates Phase I Clinical Trial of VTX-1463, a Novel TLR8 Agonist for the Treatment of Allergic Rhinitis

Alzheimer Disease - Pfizer and Medivation Initiate Phase 3 Trial of Dimebon Added to Donepezil in Patients with Alzheimer's Disease

Breast Cancer - Medifocus Inc. Reports Improved Clinical Efficacy for its Phase II, Randomized Clinical Study for the Treatment of Early Stage Breast Cancer Tumors

Clinical Trial Research - Sirion Therapeutics Announces Positive Results From Interim Analysis of Phase II Trial and Receives FDA Fast Track Designation for Fenretinide

Head and Neck Cancer - Combination of Chemo and Common Virus Continues to Show Remarkable Results in Advanced Cancer Patients

Melanoma - Oncolytics Biotech® Inc. Announces Positive Results of U.K. Phase II REOLYSIN® and Radiation Combination Clinical Trial

Millennium - Millennium to Present Oncology Pipeline Data at Annual American Association for Cancer Research Meeting

Patents - Optimer Pharmaceuticals Receives Production Patent for Lead Product Candidate Fidaxomicin

Pharmaceuticals - Novagali Pharma Completed a New Phase II With Cyclokat(R) in Dry Eye

Pharmaceuticals - Osprey Pharmaceuticals U.S.A., Inc. Initiates Phase Ib Clinical Trial in IgA Nephropathy

Pharmacyclics - Pharmacyclics announces Global Strategic Alliance with Les Laboratoires Servier

Regenerative Medicine - DePuy Spine, Inc., and Advanced Technologies and Regenerative Medicine, LLC, Begin Testing Genetically Engineered Human Protein First Patient in Randomized Pilot Study Treated at Texas Back Institute FOR DEG

Research and Markets - Clinical Laboratory Testing Volume 2: Business Strategies Reviews the Market for Clinical Laboratory Data Used in Clinical Practice

Research and Markets Ltd. - Company Profiles of the Top 50 Contract Research Organisations in Europe for CNS Diseases & Disorders

University of California - Los Angeles - New drug shows promise in treating drug-resistant prostate cancer



Return to Top of Page

-----------------------
PR Login